Guidance and regulation

  1. Zika virus: country specific risk
  2. Managing common infections: guidance for primary care
  3. Medicines: packaging, labelling and patient information leaflets
  4. The Yellow Card Scheme: guidance for healthcare professionals, patients and the public
  5. Make a payment to MHRA
See more guidance and regulation in this topic

News and communications

  1. Hydrochlorothiazide: risk of non-melanoma skin cancer, particularly in long-term use
  2. Systemic and inhaled fluoroquinolones: small increased risk of aortic aneurysm and dissection; advice for prescribing in high-risk patients
  3. Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction
  4. Support Yellow Card: improve the safety of medicines in pregnancy and breastfeeding, and in babies and children
See more news and communications in this topic

Policy papers and consultations

  1. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)
See more policy papers and consultations in this topic

Explore these sub-topics

  1. Alerts and recalls